The abnormal overexpression of NRF1 and MAZ in HCC, coupled with their positive correlation with RPS5 expression, implies a potential regulatory axis contributing to the pro-proliferative effects of RPS5 in HCC. The gene discussed is MAZ; the disease is hepatocellular carcinoma.